Solving the Problem of Insolubility: Part III
March 3, 2026
Exploring new applications for KinetiSol and the evolving role of CDMOs in bringing the next generation of complex molecules to patients
4 min read
False
March 3, 2026
Exploring new applications for KinetiSol and the evolving role of CDMOs in bringing the next generation of complex molecules to patients
4 min read
March 3, 2026
Study describes a venetoclax-regulated off-switch CAR system with dose-dependent control of receptor assembly in vitro and in vivo
2 min read
March 2, 2026
CDMO announces multi-million-euro investment to expand lyophilization and appoints Head of Site
1 min read
March 2, 2026
Why the next decade will be defined by operational reinvention, not just scientific breakthroughs
5 min read
February 27, 2026
Moderna receives MHRA approval for updated COVID-19 vaccine targeting SARS-CoV-2 variant LP.8.1
1 min read
February 27, 2026
Ahead of Rare Disease Day, leaders from iHope and PacBio explore how technology, collaboration, and policy reform can bring accurate genomic diagnosis
6 min read
February 25, 2026
A Q&A with iXCells Biotechnologies CEO, Steve Smith
8 min read
February 25, 2026
Collaboration anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
1 min read
February 24, 2026
KinetiSol’s solvent-free mixing process turns “brick dust” drugs into stable amorphous dispersions
5 min read
February 23, 2026
New technology enables faster design cycles and improved editing precision
1 min read
False
False
False